+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Syphilis Drug"

Syphilis - Pipeline Insight, 2024 - Product Thumbnail Image

Syphilis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Communicable Disease Market: A Research Overview - Product Thumbnail Image

Communicable Disease Market: A Research Overview

  • Report
  • July 2019
  • 151 Pages
  • Global
From
From
From
Syphilis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Syphilis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The Syphilis Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. Treatment for syphilis typically involves antibiotics, such as penicillin, doxycycline, and ceftriaxone. These drugs are used to kill the bacteria and prevent further damage to the body. The Syphilis Drug market is highly competitive, with a number of major pharmaceutical companies offering treatments. These include Pfizer, GlaxoSmithKline, Merck, and Sanofi. Other companies, such as Mylan and Teva Pharmaceuticals, also offer generic versions of these drugs. Additionally, there are a number of smaller companies that specialize in the development of new treatments for syphilis. Show Less Read more